Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan—Analysis of a Japanese Hospital‐Based Database
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Satoru Mitsuboshi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaetsu Hospital, Niigata, Japan. Hauptthemen laut MEDLINE: Acute Kidney Injury, Databases, Factual, International Classification of Diseases, Clinical Coding. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (Originalsprache)
Purpose
To evaluate the accuracy of diagnostic coding for acute kidney injury (AKI) in Japan.
Methods
The data analyzed were obtained from the JMDC hospital‐based administrative claims database from cases registered between April 2014 and August 2022. Only patients who underwent serum creatinine measurements two or more times with intervals of 7 days or less were eligible for inclusion. AKIs were identified by International Classification of Diseases 10th Revision (ICD‐10) codes N14 and N17. These were assessed according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
Results
A total of 467 019 patients (median age, 74 [range, 20–99] years; male, 50.9%) were eligible for inclusion. Among these patients, 1849 (0.4%) were assigned ICD‐10 codes for AKI. Among these 1849 patients, the code was assigned within 7 days of the occurrence of AKI (as defined by the KDIGO criteria) in 212 patients, within 14 days in 294 patients, and within 30 days in 386 patients. The positive predictive values and 95% confidence intervals of the ICD‐10 code for AKI at these timepoints were as follows: within 7 days, 11.5% (10.1%–13.0%); within 14 days, 15.9% (14.3%–17.6%); and within 30 days, 20.9% (19.1%–22.8%).
Conclusions
The ICD‐10 codes for AKI showed poor positive predictive values for AKI as defined by the KDIGO criteria, suggesting that it may be difficult to identify AKI using ICD‐10 codes alone in the Japanese context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Kaetsu Hospital, Niigata, Japan.
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
ORCID-Profile: Satoru Mitsuboshi, Masami Tsuchiya
Förderung
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
Zitieren
APA
Mitsuboshi, S., Imai, S., Tsuchiya, M., Kizaki, H., & Hori, S. (2025). Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan—Analysis of a Japanese Hospital‐Based Database. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70146
Vancouver
Mitsuboshi S, Imai S, Tsuchiya M, Kizaki H, Hori S. Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan—Analysis of a Japanese Hospital‐Based Database. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70146
BibTeX
@article{Mitsuboshi2025,
author = {Mitsuboshi, Satoru and Imai, Shungo and Tsuchiya, Masami and Kizaki, Hayato and Hori, Satoko},
title = {Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan—Analysis of a Japanese Hospital‐Based Database},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70146}
}
EUVIMED